A detailed history of Morgan Stanley transactions in Bio Techne Corp stock. As of the latest transaction made, Morgan Stanley holds 4,190,278 shares of TECH stock, worth $323 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,190,278
Previous 4,088,095 2.5%
Holding current value
$323 Million
Previous $315 Million 6.49%
% of portfolio
0.02%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $6.74 Million - $7.88 Million
102,183 Added 2.5%
4,190,278 $295 Million
Q4 2023

Feb 13, 2024

BUY
$52.83 - $78.22 $41.3 Million - $61.2 Million
782,269 Added 23.66%
4,088,095 $315 Million
Q3 2023

Nov 15, 2023

BUY
$67.52 - $89.42 $9.7 Million - $12.9 Million
143,716 Added 4.54%
3,305,826 $225 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $1.63 Million - $1.9 Million
-22,072 Reduced 0.69%
3,162,110 $258 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $14.4 Million - $17.5 Million
201,552 Added 6.76%
3,184,182 $236 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $223 Million - $976 Million
2,769,642 Added 1300.37%
2,982,630 $247 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $4.98 Million - $6.9 Million
-17,616 Reduced 7.64%
212,988 $60.5 Million
Q2 2022

Oct 27, 2022

BUY
$322.67 - $449.65 $40.3 Million - $56.1 Million
124,828 Added 118.01%
230,604 $79.9 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $40.3 Million - $56.1 Million
124,828 Added 118.01%
230,604 $79.9 Million
Q1 2022

Oct 27, 2022

SELL
$353.85 - $487.79 $44.2 Million - $60.9 Million
-124,828 Reduced 54.13%
105,776 $45.8 Million
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $3.75 Million - $5.18 Million
10,611 Added 11.15%
105,776 $45.8 Million
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $9.26 Million - $10.7 Million
-20,306 Reduced 17.59%
95,165 $49.2 Million
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $51.4 Million - $62.2 Million
115,471 New
115,471 $56 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.03B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.